On The Pen With Dave Knapp

Dave Knapp Man On The Mounjaro
  • 5.0(169개의 평가)
  • 의학
  • 매주 업데이트
On The Pen With Dave Knapp

Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

  1. On The Pen: The Weekly Dose 11.19.24

    3일 전

    On The Pen: The Weekly Dose 11.19.24

    Send us a texthttps://www.nature.com/articles/d41586-024-03614-9https://www.wsj.com/health/pharma/weight-loss-drugs-employer-healthcare-coverage-12817e4fhttps://www.reuters.com/business/healthcare-pharmaceuticals/medicaid-fuels-us-coverage-novo-lilly-weight-loss-drugs-2024-11-18/https://www.biospace.com/drug-delivery/novos-wegovy-launched-in-china-at-a-fraction-of-us-pricehttps://www.wsj.com/health/pharma/eli-illy-novo-ozempic-zepbound-copycats-e6171fddro.co/OTPSupport the showDNF10 Peptide S...

    22분
  2. CNN Special: Is Ozempic For You? With Dr. Gupta OTP REVIEW

    4일 전

    CNN Special: Is Ozempic For You? With Dr. Gupta OTP REVIEW

    Send us a textDave reviews the CNN special with Dr Sanjay Gupta on GLP-1 medications.ro.co/OTPSupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join👉 My Amazon Affiliate Store:https://www.amazon.com/shop/ma...

    21분
  3. Dr Spencer Nadolsky: Docs Who Lift Pod | OTP Eps 90

    11월 15일

    Dr Spencer Nadolsky: Docs Who Lift Pod | OTP Eps 90

    Send us a textDr Spencer Nadolski of the “Docs Who Life” podcast joins Dave to recap obesity week, and to deep dive into Dave’s ongoing struggle with obesity and type 2 diabetes.ro.co/OTP& so much moreA bi-monthly podcast where we share the stories of our Caregivers, patients and...Listen on: Apple Podcasts SpotifySupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On...

    1시간 38분
  4. Novo Nordisk's War on Compound Semaglutide, Maritide Has Some Negative News

    11월 12일

    Novo Nordisk's War on Compound Semaglutide, Maritide Has Some Negative News

    Send us a textIn this episode of On The Pen: The Weekly Dose, host Dave Knapp dives into the latest updates in obesity medicine, with insightful takes on current treatment breakthroughs, new medication approvals, and tips on navigating healthcare options. This week’s deep dive also touches on emerging trends in GLP-1 therapy and how recent shifts may impact accessibility for patients. Whether you’re just starting your journey or a long-time follower of GLP-1 news, this episode brings you the ...

    28분
  5. Viking Therapeutics and AstraZeneca Steal The Show at Obesity Week!

    11월 5일

    Viking Therapeutics and AstraZeneca Steal The Show at Obesity Week!

    Send us a textSemaglutide News: https://www.onthepen.com/post/select-trial-update-semaglutide-s-cardiovascular-benefits-and-psychiatric-safety-profile-highlighteViking Therapeutics News:https://www.onthepen.com/post/vk2735-vikingtideAstraZeneca News: https://www.onthepen.com/post/astrazeneca-s-azd5004-a-power-move-in-obesity-medicinero.co/OTP& so much moreA bi-monthly podcast where we share the stories of our Caregivers, patients and...Listen on: Apple Podcasts SpotifySupport ...

    31분
  6. Lilly Earnings Call Analysis: Why Zepbound Missed Earnings

    10월 31일

    Lilly Earnings Call Analysis: Why Zepbound Missed Earnings

    Send us a textDave brings his analysis of the Q3 Eli Lilly earnings call, and how it relates to the future of access to obesity medicine. Also there is an important clarification on the Zepbound savings card that you should not miss.#Zepbound #Mounjaro #Tirzepatidero.co/OTP& so much moreA bi-monthly podcast where we share the stories of our Caregivers, patients and...Listen on: Apple Podcasts SpotifySupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFF...

    39분

  7. 10월 29일

    New Zepbound Savings Card, GLP-1 Accessibility Landscape Evolves

    Send us a textLilly Releases 2025 Zepobound Savings Card Details:https://www.onthepen.com/post/breaking-zepbound-savings-card-2025-released-what-you-need-to-knowNovo Nordisk Petitions FDA to Add Semaglutide to DDC list: https://www.onthepen.com/post/compound-semaglutideEli Lilly Petiioned FDA in Augus to add Tirzepatide to DDC list: https://www.onthepen.com/post/compound-tirzepatidero.co/OTPSupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE...

    19분
  8. Inside the Legal Battle for Compound Tirzepatide: What You Need to Know from Industry Insider Scott Brunner!

    10월 25일

    Inside the Legal Battle for Compound Tirzepatide: What You Need to Know from Industry Insider Scott Brunner!

    Send us a textAn article on the news broken by Mr Brunner on compound Tirzepatide: https://www.onthepen.com/post/compound-tirzepatidea4pc.orgcompounding.comro.co/OTP& so much moreA bi-monthly podcast where we share the stories of our Caregivers, patients and...Listen on: Apple Podcasts SpotifySupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIE...

    39분
모두 보기(68개)

5
최고 5점
169개의 평가

소개

Dave Knapp brings you your weekly dose of everything in the news about incretin mimetic, diabetes and obesity therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

정보

  • 제작진
    Dave Knapp Man On The Mounjaro
  • 방송 연도
    2024년
  • 에피소드
    68
  • 등급
    전체 연령 사용가
  • 저작권
    © 2024 On The Pen With Dave Knapp
  • 웹사이트 보기
    On The Pen With Dave Knapp

좋아할 만한 다른 항목

무삭제판 에피소드를 청취하려면 로그인하십시오.

이 프로그램의 최신 정보 받기

프로그램을 팔로우하고, 에피소드를 저장하고, 최신 소식을 받아보려면 로그인하거나 가입하십시오.
국가 또는 지역 선택

아프리카, 중동 및 인도

아시아 태평양

유럽

라틴 아메리카 및 카리브해

미국 및 캐나다